Cargando…
Safety Summary of the Selective Cytopheretic Device: A Review of Safety Data Across Multiple Clinical Trials in ICU Patients With Acute Kidney Injury and Multiple Organ Failure
OBJECTIVES: Acute kidney injury (AKI) requiring continuous kidney replacement therapy is a significant complication in ICU patients with mortality rates exceeding 50%. A dysregulated immune response can lead to systemic inflammation caused by hyperactivity of pro-inflammatory neutrophils and monocyt...
Autores principales: | Humes, H. David, Goldstein, Stuart L., Yessayan, Lenar T., Catanzaro, David A., Scribe, Emily C., Iyer, Sai Prasad N., Chung, Kevin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589552/ https://www.ncbi.nlm.nih.gov/pubmed/37868028 http://dx.doi.org/10.1097/CCE.0000000000000995 |
Ejemplares similares
-
Use of the Selective Cytopheretic Device in Critically Ill Children
por: Goldstein, Stuart L., et al.
Publicado: (2020) -
Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients
por: Yessayan, Lenar T., et al.
Publicado: (2022) -
A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury
por: Tumlin, James A., et al.
Publicado: (2015) -
Use of extracorporeal immunomodulation in a toddler with hemophagocytic lymphohistiocytosis and multisystem organ failure
por: Goldstein, Stuart L., et al.
Publicado: (2022) -
ICU-acquired weakness
por: Vanhorebeek, Ilse, et al.
Publicado: (2020)